Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Teva
Chinese Patent Office
Cerilliant
Baxter
Daiichi Sankyo
Cantor Fitzgerald
Merck
Cipla

Generated: May 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,247,400

« Back to Dashboard

Which drugs does patent 8,247,400 protect, and when does it expire?

Patent 8,247,400 protects TEFLARO and is included in one NDA.

This patent has two patent family members in two countries.
Summary for Patent: 8,247,400
Title:Cephem compounds useful for the treatment of bacterial infections
Abstract: The present invention relates to new cephem compounds useful for the treatment of bacterial infections of formula I: ##STR00001## The invention also relates to methods of preparing the compounds, pharmaceutical compositions comprising the compounds, and to methods of treatment using the compounds. The new cephem compounds are stable, exhibit good solubility, and are particularly well suited for, e.g., parenteral administration for the treatment of bacterial infections.
Inventor(s): Dedhiya; Mahendra G. (Pomona, NY), Singh; Brahma N. (Syosset, NY)
Assignee:
Application Number:12/710,417
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,247,400
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent 8,247,400

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Allergan Sales Llc TEFLARO ceftaroline fosamil POWDER;IV (INFUSION) 200327-001 Oct 29, 2010 RX Yes No ➤ Sign Up ➤ Sign Up Y METHOD OF TREATING BACTERIAL INFECTIONS ➤ Sign Up
Allergan Sales Llc TEFLARO ceftaroline fosamil POWDER;IV (INFUSION) 200327-002 Oct 29, 2010 RX Yes Yes ➤ Sign Up ➤ Sign Up Y METHOD OF TREATING BACTERIAL INFECTIONS ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
McKesson
Harvard Business School
Citi
Argus Health
Chubb
Fish and Richardson
Mallinckrodt
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.